Alstom S.A: Half-year liquidity contact statement for Alstom
8 January 2025 – Under the liquidity contract entrusted by Alstom to Rothschild Martin Maurel, as of December 31, 2024, the following resources appeared in the liquidity account:
- 0 securities
- €18,004,305
Over the period from 2024/11/21 to 2024/12/31, the number of transactions processed is as followed:
| Number of transactions carried out | Number of securities traded | Amount of transactions (in €) | |
| Buy | 3,913 | 1,279,463 | 27,538,354.89 |
| Sell | 5,057 | 1,279,463 | 27,542,659.86 |
When it was implemented on November 21st, 2024, the following resources appeared in the liquidity account:
€18,000,000
The implementation of this report is carried out in accordance with AMF decision n°2021-01 of June 22, 2021 renewing the introduction of liquidity contracts on equity securities as an accepted market practice.
The complete transaction template is available in the attached pdf document.
ALSTOM™ is a protected trademark of the Alstom Group.
| About Alstom | |||
| Alstom commits to contribute to a low carbon future by developing and promoting innovative and sustainable transportation solutions that people enjoy riding. From high-speed trains, metros, monorails, trams, to turnkey systems, services, infrastructure, signalling and digital mobility, Alstom offers its diverse customers the broadest portfolio in the industry. With its presence in 64 countries and a talent base of over 84,700 people from 184 nationalities, the company focuses its design, innovation, and project management skills to where mobility solutions are needed most. Listed in France, Alstom generated revenues of €17.6 billion for the fiscal year ending on 31 March 2024. For more information, please visit www.alstom.com. | |||
| Contacts | Press Philippe MOLITOR - Tel. : +33 (0) 7 76 00 97 79 [email protected] Thomas ANTOINE - Tel. : +33 (0) 6 11 47 28 60 [email protected] Investor Relations Martin VAUJOUR – Tél : +33 (0) 6 88 40 17 57 [email protected] Estelle MATURELL ANDINO – Tél : +33 (0) 6 71 37 47 56 [email protected] | ||
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
- HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDB
- Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share